Publiziert in: Marktpuls, Unternehmen
Frei

Marco Gadola appointed new CEO of Straumann Freitag, 04. Januar 2013 - 07:33

Marco Gadola appointed new CEO of Straumann

Basel 4 January 2013 – Straumann’s Board of Directors today announced the appointment of Marco Gadola as the Group’s new Chief Executive Officer, replacing Beat Spalinger, who is leaving the company by mutual agreement with the Board.

Mr Gadola was Chief Financial Officer and Executive Vice President Operations at Straumann from 2006 to 2008, when he left to pursue a career development opportunity at Panalpina, a world leader in supply chain management. Having started as Panalpina’s Chief Financial Officer, he became Regional CEO Asia Pacific in 2012, with overall responsibility for the regional business of approx. CHF 1.2 billion.

Mr Gadola will take up his new responsibilities before the beginning of April 2013. Until then, Straumann’s Chairman, Gilbert Achermann, will resume responsibility as CEO ad interim. Roland Hess, who heads the Audit Committee of the Board of Directors, will act as Lead Director for the same interim period.

Gilbert Achermann commented: “The dental markets have become increasingly challenging, squeezing topline and profitability. The Board is convinced that the Group’s Vision, business fundamentals, strategic plan and structure are intact. However, to take the organization forward requires specific leadership qualities and impulses at top level, and we believe that Marco Gadola is the right person to do this. In addition to his excellent understanding of our business and company, he has proven himself as an engaging and entrepreneurial leader who sets himself ambitious objectives and consistently follows through to achieve them. We are convinced that he will revitalize growth, even in this challenging environment”.

The outgoing Chief Executive, Beat Spalinger, joined Straumann as CFO in 2008 and took over as CEO in March 2010. Since then, he has navigated Straumann through economic recession, market contraction and stiff currency headwind. He has adapted the organization to the market environment, established a new strategic plan and successfully led the company’s largest acquisition to date. During his tenure, Straumann has maintained its position as the global leader in implant dentistry.

“Beat Spalinger has served Straumann untiringly with devotion and passion and the company has benefitted significantly over the past years from his organizational, operational, and strategic skills. On behalf of the Board and everyone at Straumann, I would like to thank him for his valuable contributions and wish him all the best for the future”, Mr Achermann added.

About Marco Gadola

Aged 49, Marco Gadola has a strong executive track record in a broad range of global businesses. He returns to Straumann from Panalpina, the company he joined in 2008 as CFO and where he was recently given responsibility for the Asia Pacific business.

Prior to joining Straumann as CFO and Executive Vice President Operations in 2006, he spent five years at Hero, the Swiss-based international food group, where he was also CFO and responsible for IT and Operations. Previously, he spent nine years at the international construction tool manufacturer Hilti, where he held a number of senior commercial/sales and finance-related positions in various countries. Before that, he worked for Sandoz International Ltd. as Audit Manager and for Swiss Bank Corporation, Basel, in Corporate Finance.

Mr Gadola, who is Swiss, graduated from Basel University in business administration and economics and completed various programs at the London School of Economics and at IMD in Lausanne. He has served on the Board of Directors of Calida, the Swiss textile group, since 2011.

About Straumann

Headquartered in Basel, Switzerland, the Straumann Group (SIX: STMN) is a global leader in implant and restorative dentistry and oral tissue regeneration. In collaboration with leading clinics, research institutes and universities, Straumann researches, develops and manufactures dental implants, instruments, prosthetics and tissue regeneration products for use in tooth replacement and restoration solutions or to prevent tooth loss. Straumann employs approx. 2500 people worldwide and its products and services are available in more than 70 countries through its broad network of distribution subsidiaries and partners.

Straumann Holding AG, Peter Merian-Weg 12, 4002 Basel, Switzerland.

Phone: +41 (0)61 965 11 11 / Fax: +41 (0)61 965 11 01

E-mail: investor.relations@straumann.com or corporate.communication@straumann.com

Homepage: www.straumann.com

Contacts:

Corporate Communication:

Mark Hill

+41 (0)61 965 13 21

Thomas Konrad

+41 (0)61 965 15 46

Investor Relations:

Fabian Hildbrand

+41 (0)61 965 13 27

Straumann Media Releases subscription:

www.straumann.com/en/home/investor-relations/ir-contacts-and-services/subscription.html

Disclaimer

This release contains certain forward-looking statements, which can be identified by the use of terminology such as ‘will’, ‘believe‘, or similar wording. Such forward-looking statements reflect the current views of management and are subject to known and unknown risks, uncertainties and other factors that may cause actual results, performance or achievements of the Group to differ materially from those expressed or implied. These include risks related to the success of and demand for the Group’s products, the potential for the Group’s products to become obsolete, the Group’s ability to defend its intellectual property, the Group’s ability to develop and commercialize new products in a timely manner, the dynamic and competitive environment in which the Group operates, the regulatory environment, changes in currency exchange rates, the Group’s ability to hire and retain key talented individuals, to generate revenues and profitability, to realize its expansion projects in a timely manner, and to maintain its business relationships with suppliers, customers and other third parties. Should one or more of these risks or uncertainties materialize, or should underlying assumptions prove incorrect, actual results may vary materially from those described in this report. Straumann is providing the information in this release as of this date and does not undertake any obligation to update any forward-looking statements contained in it as a result of new information, future events or otherwise.

# # #